Cotización Denali Capital Acquisition - DECA

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

11.98

Postura de Compra

11.93

Postura de Venta

12.00

Volume Operado de la Acción

1,962

11.98 Rango del Día 11.99

4.05 Rango de 52 semanas 13.20

Capitalización de Mercado [m]

60.473M

Precio Anterior

11.965

Precio de Apertura

11.99

Hora

100

11.98

Última hora de negociación

10:42:50

Volumen financiero

US$ 23,515

Precio Promedio Ponderado

11.985

Volumen promedio (3 m)

3,034

Acciones en circulación

5,047,829

Rendimiento del Dividendo

Ratio Precio/Utilidad

95.53

Beneficio por acción (BPA)

0.13

turnover

Beneficio neto

633k

Denali Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Denali Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Sector

Blank Checks

Industria

Blank Checks

Sede

Grand Cayman, Cym

Fundado

Denali Capital Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker DECA. The last closing price for Denali Capital Acquisition was US$11.97. Over the last year, Denali Capital Acquisition shares have traded in a share price range of US$ 4.05 to US$ 13.20.

Denali Capital Acquisition currently has 5,047,829 shares in issue. The market capitalisation of Denali Capital Acquisition is US$60.40 million. Denali Capital Acquisition has a price to earnings ratio (PE ratio) of 95.53.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously

As previously announced, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) entered into...

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Scilex notified NASDAQ on October 28, 2024 that it has set a record date of November 7, 2024 (the “Record Date”) for the dividend of Scilex preferred stock to Scilex’s stockholders and certain...

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur a

Semnur is currently in discussions regarding strategic regional and/or worldwide collaborations and potential outright acquisition of SP-102. Any such transactions may have the potential to...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account...

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the “SPAC”) announce the...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.05	-0.415627597672	12.03	13.2	11.9	6855	11.96517991	CS
4	0.14	1.18243243243	11.84	13.2	11.84	1973	11.94255052	CS
12	0.3901	3.36586165541	11.5899	13.2	11.34	3034	11.83504517	CS
26	0.62	5.45774647887	11.36	13.2	11.34	2374	11.69227434	CS
52	6.73	128.19047619	5.25	13.2	4.05	16808	8.28418785	CS
156	2.03	20.4020100503	9.95	14.1	4.05	23202	9.91494562	CS
260	2.03	20.4020100503	9.95	14.1	4.05	23202	9.91494562	CS

DECA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Denali Capital Acquisition?

El precio actual de las acciones de Denali Capital Acquisition es US$ 11.98

¿Cuántas acciones de Denali Capital Acquisition están en circulación?

Denali Capital Acquisition tiene 5,047,829 acciones en circulación

¿Cuál es la capitalización de mercado de Denali Capital Acquisition?

La capitalización de mercado de Denali Capital Acquisition es USD 60.4M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Denali Capital Acquisition?

Denali Capital Acquisition ha negociado en un rango de US$ 4.05 a US$ 13.20 durante el último año

¿Cuál es el ratio PE (precio/beneficio) de Denali Capital Acquisition?

El ratio precio/beneficio de Denali Capital Acquisition es 95.53

¿Cuál es la moneda de reporte de Denali Capital Acquisition?

Denali Capital Acquisition presenta sus resultados financieros en USD

¿Cuál es el último beneficio anual de Denali Capital Acquisition?

El último beneficio anual de Denali Capital Acquisition es USD 633k

¿Cuál es la dirección registrada de Denali Capital Acquisition?

La dirección registrada de Denali Capital Acquisition es MAPLES CORPORATE SERVICES LIMITED, PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104

¿En qué sector industrial opera Denali Capital Acquisition?

Denali Capital Acquisition opera en el sector BLANK CHECKS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
JGAurora Mobile Ltd	US$ 16.70 (177.77%)	28.74M
YIBOPlanet Image International Ltd	US$ 4.79 (122.79%)	28.12M
AKROAkero Therapeutics Inc	US$ 50.75 (93.85%)	11.66M
TOIIWOncology Institute Inc	US$ 0.040742 (82.70%)	214.02k
HWHHWH International Inc	US$ 0.48695 (69.26%)	373.75M
ALLKAllakos Inc	US$ 0.2391 (-80.24%)	33.69M
NXUNXU Inc	US$ 0.295 (-52.11%)	8.73M
VERUVeru Inc	US$ 0.5927 (-51.02%)	36.22M
WOKWORK Medical Technology Group Ltd	US$ 2.81 (-41.70%)	725.78k
AVGXDefiance Daily Target 2X Long AVGO ETF	US$ 21.65 (-38.95%)	3.35M
NVDANVIDIA Corporation	US$ 118.095 (-17.20%)	513.04M
HWHHWH International Inc	US$ 0.48695 (69.26%)	373.75M
HOLOMicroCloud Hologram Inc	US$ 1.7298 (11.60%)	178.53M
ONCOOnconetix Inc	US$ 0.6053 (26.10%)	178.2M
RGTIRigetti Computing Inc	US$ 12.17 (-7.80%)	100.77M